5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)ISOBENZOFURAN-1(3H)-ONE, 95.0%, 10g

3,3,3-Trifluoro-2-(7-fluoro-1H-indol-3-yl)propanoic acid, 1g

1-methyl-3-nitro-1H-1,2,4-triazole, 95%, 5g

Sample vials ROTILABO® with beaded rim ND11, Brown glass, with labelling space, 1.5 ml, 100 Piece(s)

1-tert-Butyl 2-methyl 1H-pyrrole-1,2(2H,5H)-dicarboxylate, 98%, 5g

4-(2-Methyltetrahydro-2H-pyran-4-yl)-pyridine, 1g

(R)-Octahydropyrrolo[1,2-a]pyrazine dihydrochloride, 95.0%, 25g

N-(piperidin-4-yl)cyclopropanesulfonamide hydrochloride, 95.0%, 250mg

2-(2,4-Dichlorobenzyl)-1H-benzo[d]imidazole, 95.0%, 25g

2-Chloro-1-(2,7-dichloro-9H-fluoren-4-yl)ethanone, 95.0%, 250mg

1,4,9-Trioxadispiro[4.2.48.25]tetradecan-12-one, 98%, 250mg

Ethyl 3,6-dichloropyridazine-4-carboxylate, 95.0%, 25g

11-Oxa-2,7,9-triazadodec-7-enoic acid, 3-carboxy-10-oxo-12-phenyl-8-[[(phenylmethoxy)carbonyl]amino]-, 1-(9H-fluoren-9-ylmethyl) ester, (3S)-, 100mg